Israel Englander Xencor Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Xencor Inc stock. As of the latest transaction made, Millennium Management LLC holds 1,414,296 shares of XNCR stock, worth $37.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,414,296

Previous 820,871 72.29%

Holding current value

$37.6 Million

Previous $15.5 Million 83.03%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.7 - $21.65 $9.32 Million - $12.8 Million	593,425 Added 72.29%	1,414,296 $28.4 Million
Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $38,332 - $51,572	-2,105 Reduced 0.26%	820,871 $15.5 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $8.82 Million - $12.5 Million	472,762 Added 134.99%	822,976 $18.2 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $475,105 - $615,653	28,742 Added 8.94%	350,214 $7.44 Million
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $7.72 Million - $9.32 Million	311,624 Added 3164.34%	321,472 $8.03 Million
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $799,130 - $1.14 Million	-30,795 Reduced 75.77%	9,848 $275,000
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $790,082 - $983,539	31,871 Added 363.33%	40,643 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $5.86 Million - $7.72 Million	-237,995 Reduced 96.45%	8,772 $228,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $144,220 - $211,947	-7,306 Reduced 2.88%	246,767 $6.75 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $6.16 Million - $9.61 Million	230,923 Added 997.51%	254,073 $6.78 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $85,521 - $110,337	2,540 Added 12.32%	23,150 $929,000
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $3.57 Million - $4.15 Million	-116,376 Reduced 84.95%	20,610 $673,000
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $3.73 Million - $4.85 Million	108,576 Added 382.18%	136,986 $4.73 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $629,616 - $831,260	15,428 Added 118.84%	28,410 $1.22 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $74,835 - $97,308	2,043 Added 18.68%	12,982 $566,000
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $329,154 - $470,595	10,939 New	10,939 $424,000
Q2 2020 Aug 14, 2020	SELL	$27.76 - $33.42 $1.57 Million - $1.89 Million	-56,588 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$20.69 - $37.79 $1.17 Million - $2.14 Million	56,588 New	56,588 $1.69 Million
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $55.8 Million - $76.6 Million	-1,655,086 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$29.6 - $40.93 $20 Million - $27.6 Million	674,021 Added 68.7%	1,655,086 $67.7 Million
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $29 Million - $40.2 Million	981,065 New	981,065 $10 Million
Q2 2018 Aug 14, 2018	SELL	$28.41 - $42.41 $1.25 Million - $1.86 Million	-43,936 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$21.18 - $33.78 $476,507 - $759,982	-22,498 Reduced 33.87%	43,936 $1.32 Million
Q4 2017 Feb 14, 2018	BUY	$19.29 - $24.83 $1.28 Million - $1.65 Million	66,434	66,434 $1.46 Million

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.59B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account